Bicycle Therapeutics Ltd (BCYC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $236.22M
Last updated: Nov 17, 2026 at 11:04 AM ET
Bicycle Therapeutics Ltd (BCYC) Earnings: Report Dates and Results
Bicycle Therapeutics (BCYC) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Bicycle Therapeutics reported EPS of -$0.15, above the -$0.30 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
BCYC has an expected report date of Mar 15, 2027.
Earnings History
Of the 30 quarters below that had an estimate, BCYC beat 13 and missed 17. Revenue for the quarter ended Sep 30, 2026 was $34.06M, up 190.4% from $11.73M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.15 | -$0.30 | -$0.65 - -$0.04 | +50.00% | Beat | N/A | 8 | 2 up, 0 down | Oct 29, 2026 | $34.06M |
| Jun 30, 2026 | -$0.72 | -$0.37 | -$0.75 - -$0.37 | -94.59% | Miss | N/A | 7 | 1 up, 1 down | Jul 30, 2026 | $629000 |
| Mar 31, 2026 | -$0.87 | -$0.67 | -$0.80 - -$0.44 | -29.85% | Miss | N/A | 9 | 5 up, 0 down | Apr 30, 2026 | $887000 |
| Dec 31, 2025 | -$0.29 | -$0.94 | -$1.18 - -$0.79 | +69.06% | Beat | N/A | 11 | N/A | Mar 17, 2026 | $47.95M |
| Sep 30, 2025 | -$0.85 | -$1.07 | -$1.27 - -$0.74 | +20.56% | Beat | N/A | 8 | 1 up, 5 down | Oct 30, 2025 | $11.73M |
| Jun 30, 2025 | -$1.14 | -$0.93 | -$1.07 - -$0.69 | -22.58% | Miss | N/A | 7 | 0 up, 1 down | Aug 8, 2025 | $2.92M |
| Mar 31, 2025 | -$0.88 | -$0.85 | -$0.91 - -$0.69 | -3.53% | Miss | N/A | 4 | 0 up, 1 down | May 1, 2025 | $9.98M |
| Dec 31, 2024 | -$0.81 | -$0.85 | -$1.20 - -$0.68 | +4.59% | Beat | N/A | 10 | 1 up, 0 down | Feb 25, 2025 | $3.71M |
| Sep 30, 2024 | -$0.72 | -$0.78 | -$1.05 - -$0.54 | +7.69% | Beat | N/A | 13 | 0 up, 0 down | Oct 31, 2024 | $2.68M |
| Jun 30, 2024 | -$0.77 | -$1.11 | -$1.35 - -$0.89 | +30.63% | Beat | N/A | 12 | 2 up, 0 down | Aug 6, 2024 | $9.36M |
| Mar 31, 2024 | -$0.62 | -$1.21 | -$1.40 - -$1.03 | +48.76% | Beat | N/A | 11 | 0 up, 1 down | May 2, 2024 | $19.53M |
| Dec 31, 2023 | -$1.16 | -$1.23 | -$1.65 - -$0.67 | +5.69% | Beat | N/A | 13 | 1 up, 0 down | Feb 20, 2024 | $5.33M |
| Sep 30, 2023 | -$1.26 | -$1.06 | -$1.85 - -$0.23 | -18.87% | Miss | N/A | 14 | 0 up, 0 down | Nov 2, 2023 | $5.35M |
| Jun 30, 2023 | -$1.41 | -$1.07 | -$1.65 - -$1.05 | -31.78% | Miss | N/A | 12 | 0 up, 0 down | Aug 3, 2023 | $11.40M |
| Mar 31, 2023 | -$1.30 | -$0.96 | N/A | -35.42% | Miss | N/A | 13 | 1 up, 0 down | May 4, 2023 | $4.90M |
| Dec 31, 2022 | -$1.01 | -$1.06 | -$1.20 - -$0.94 | +4.72% | Beat | N/A | 15 | 0 up, 0 down | Feb 28, 2023 | $3.19M |
| Sep 30, 2022 | -$0.96 | -$0.91 | -$1.15 - -$0.44 | -5.49% | Miss | N/A | 15 | 0 up, 0 down | Nov 3, 2022 | $3.04M |
| Jun 30, 2022 | -$0.90 | -$0.81 | -$1.15 - -$0.66 | -11.11% | Miss | N/A | 14 | 0 up, 0 down | Aug 4, 2022 | $4.38M |
| Mar 31, 2022 | -$0.93 | -$0.72 | -$0.84 - -$0.36 | -29.17% | Miss | N/A | 12 | 0 up, 0 down | May 5, 2022 | $3.86M |
| Dec 31, 2021 | -$0.63 | -$0.61 | -$1.23 - -$0.13 | -3.28% | Miss | N/A | 13 | 1 up, 0 down | Mar 1, 2022 | $3.77M |
| Sep 30, 2021 | -$0.59 | -$0.63 | -$0.76 - -$0.26 | +6.35% | Beat | N/A | 9 | 1 up, 0 down | Nov 4, 2021 | $4.33M |
| Jun 30, 2021 | -$0.74 | -$0.67 | -$1.08 - -$0.58 | -10.45% | Miss | N/A | 8 | N/A | Aug 5, 2021 | $1.78M |
| Mar 31, 2021 | -$0.73 | -$0.71 | -$0.95 - -$0.53 | -2.82% | Miss | N/A | 6 | N/A | May 6, 2021 | $1.81M |
| Dec 31, 2020 | -$0.83 | -$0.47 | -$0.77 - -$0.20 | -76.60% | Miss | N/A | 8 | N/A | Mar 11, 2021 | $3.85M |
| Sep 30, 2020 | -$0.52 | -$0.53 | -$0.72 - -$0.12 | +1.89% | Beat | N/A | 8 | N/A | Nov 5, 2020 | $3.84M |
| Jun 30, 2020 | -$0.67 | -$0.46 | -$0.71 - -$0.27 | -45.65% | Miss | N/A | 7 | N/A | Aug 5, 2020 | $1.57M |
| Mar 31, 2020 | -$0.63 | -$0.38 | -$0.55 - $1.09 | -65.79% | Miss | N/A | 6 | N/A | May 7, 2020 | $1.13M |
| Dec 31, 2019 | -$0.25 | -$0.52 | -$0.58 - -$0.47 | +51.92% | Beat | N/A | 5 | N/A | Mar 10, 2020 | $5.28M |
| Sep 30, 2019 | -$0.53 | -$0.69 | -$0.88 - -$0.33 | +23.19% | Beat | N/A | 4 | N/A | Nov 7, 2019 | $614000 |
| Jun 30, 2019 | -$0.66 | -$0.62 | -$0.62 - -$0.29 | -6.45% | Miss | N/A | 4 | N/A | Aug 8, 2019 | $1.52M |
| Mar 31, 2019 | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 23, 2019 | $6.38M |
| Sep 30, 2018 | -$0.78 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 21, 2018 | $1.61M |
| Jun 30, 2018 | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2018 | $1.66M |
| Mar 31, 2018 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2018 | $2.81M |
| Dec 31, 2017 | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2017 | $655000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$3.16, after -$2.92 the year before. It was -$0.76 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$3.16 | N/A |
| Dec 31, 2024 | -$2.92 | N/A |
| Dec 31, 2023 | -$5.13 | N/A |
| Dec 31, 2022 | -$3.80 | N/A |
| Dec 31, 2021 | -$2.69 | N/A |
| Dec 31, 2020 | -$2.65 | N/A |
| Dec 31, 2019 | -$2.67 | N/A |
| Dec 31, 2018 | -$1.64 | N/A |
| Dec 31, 2017 | -$1.22 | N/A |
| Dec 31, 2016 | -$0.76 | N/A |
Frequently Asked Questions About BCYC
When is Bicycle Therapeutics's next earnings date?
Bicycle Therapeutics's next earnings report is expected for Mar 15, 2027.
Did BCYC beat earnings estimates last quarter?
Yes. Bicycle Therapeutics reported EPS of -$0.15 for the quarter ended Sep 30, 2026, above the -$0.30 estimate, a 50.00% surprise.
What EPS do analysts expect from BCYC next quarter?
The consensus EPS estimate for Bicycle Therapeutics for the quarter ending Dec 31, 2026 is -$0.44 from 12 analysts, with estimates from -$0.64 to $0.33.
How often does BCYC beat earnings estimates?
Bicycle Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -0.79%.
BCYC pages: Overview, Earnings, Forecast, Financials, Competitors